Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

David J. Straus*, Madeleine Duvic, Timothy Kuzel, Steven Horwitz, Marie France Demierre, Patricia Myskowski, Steven Steckel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science